You are not logged in.
This means
you CAN ONLY VIEW reports that were published prior to Sunday, February 25, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
 MIDDAY BREAKOUTS REPORT - THURSDAY, JANUARY 16TH, 2014
Previous Mid Day Report Next Mid Day Report >>>
|
|
DOW 16402.92 -79.02 (-0.48%) | NASDAQ 4211.37 -3.51 (-0.08%) | S&P 500 1843.22 -5.16 (-0.28%)
|
Time of Screening :
1/16/2014 12:11:53 PM Report Released :
1/16/2014 12:55:12 PM
Price is:
Above 52W High and Less Than 52W High
but within 12% of the 52 Week High
Volume Is:
At least 75% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(50 DAV) |
52 Wk Hi
% From Hi |
Date
Featured |
Price
Featured |
Pivot Point |
|
Max Buy |
GNRC
- NYSE
Generac Hldgs Inc
|
$51.60
|
-3.64
-6.59%
|
$54.01
|
741,619
123.62% of 50 DAV
50 DAV is 599,900
|
$57.29
-9.93%
|
11/26/2013 |
$53.02
|
PP = $52.42
MB = $55.04 |
Most Recent Note - 1/16/2014 12:32:33 PM
G - Gapped down today and violated its 50 DMA line with a considerable loss on above average volume triggering a technical sell signal. Prior highs in the $52 area may act as support. A prompt rebound above its 50 DMA line is needed for its outlook to improve.
>>> The latest Featured Stock Update with an annotated graph appeared on 1/2/2014. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HLF
- NYSE
Herbalife Ltd
|
$73.49
|
-5.89
-7.42%
|
$76.30
|
3,565,053
128.20% of 50 DAV
50 DAV is 2,780,800
|
$83.51
-12.00%
|
11/22/2013 |
$72.21
|
PP = $75.04
MB = $78.79 |
Most Recent Note - 1/16/2014 12:32:56 PM
G - Gapped down today and undercut prior highs in the $74 area while testing support at its 50 DMA line. Disciplined investors always limit losses if any stock falls more than -7% from their purchase price.
>>> The latest Featured Stock Update with an annotated graph appeared on 12/30/2013. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PCLN
- NASDAQ
Priceline.com Inc
|
$1,182.11
|
+9.25
0.79%
|
$1,189.99
|
510,117
85.45% of 50 DAV
50 DAV is 597,000
|
$1,198.75
-1.39%
|
12/18/2013 |
$1,156.20
|
PP = $1,198.85
MB = $1,258.79 |
Most Recent Note - 1/16/2014 12:46:57 PM
Y - Perched within close striking distance of its 52-week high while consolidating above its 50 DMA line which has recently acted as support. A volume-driven gain above its pivot point may trigger a technical buy signal, meanwhile, its 50 DMA line and prior low ($1,113.01 on 1/06/13) define near-term support to watch.
>>> The latest Featured Stock Update with an annotated graph appeared on 1/6/2014. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
 |
Symbol - Exchange - Industry Group
Company Name |
Last |
Chg |
Day
High |
52 WK Hi |
% From Hi |
Volume
% DAV |
DAV |
AEIS
- NASDAQ - ELECTRONICS - Diversified Electronics
Advanced Energy Inds
|
$27.00 |
+1.45
5.68%
|
$27.22
|
$26.73
|
1.01% |
514,860
101.97%
|
504,900
|
Most Recent Note for AEIS - 1/16/2014 12:14:11 PM
Rallying for a 3rd consecutive big gain another new 52-week high today. Reported earnings +96% on +22% sales for the Sep '13 quarter. Found support near its 50 DMA line during its consolidation since noted with caution in the 11/06/13 mid-day report - "It may be an interesting turnaround story, however, fundamental concerns remain as prior mid-day reports cautioned - 'Earnings history is not a match with the fact-based investment system's guidelines (C and A criteria).'"
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AGX
- NYSE - MATERIALS & CONSTRUCTION - Heavy Construction
Argan Inc
|
$30.10 |
-0.50
-1.63%
|
$30.62
|
$30.81
|
-2.30% |
114,540
119.31%
|
96,000
|
Most Recent Note for AGX - 1/16/2014 12:15:43 PM
Perched at its 52-week high today, pulling back after tallying 8 consecutive volume-driven gains. Reported earnings +93% on -15% sales for the Oct '13 quarter. Held its ground and rallied since noted with caution in the 12/09/13 mid-day report - "Reported earnings +98% on -30% sales for the Jul '13 quarter. The Building -Heavy Construction firm is not a match with the fact-based investment system's guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BAC
- NYSE - BANKING - Money Center Banks
Bank Of America Corp
|
$17.06 |
-0.09
-0.52%
|
$17.14
|
$17.42
|
-2.07% |
109,575,813
110.43%
|
99,224,900
|
Most Recent Note for BAC - 1/16/2014 12:16:58 PM
Gapped up for a new 52-week high on the prior session. The 1/15/14 mid-day report cautioned members - "Quarterly and annual earnings history (C and A criteria) is not a match with the fact-based investment system's guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BDC
- NYSE - MANUFACTURING - Industrial Electrical Equipmen
Belden Inc
|
$69.78 |
-0.74
-1.05%
|
$70.87
|
$72.07
|
-3.18% |
160,319
76.82%
|
208,700
|
Most Recent Note for BDC - 1/16/2014 12:18:36 PM
Found support this week near its 50 DMA line while consolidating near its all-time high. Last noted in the 12/10/13 mid-day report with caution - "Quarterly and annual earnings history (C and A criteria) history has not been strong and steady."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CLB
- NYSE - ENERGY - Oil & Gas Equipment & Services
Core Laboratories Nv
|
$188.29 |
-1.57
-0.83%
|
$190.84
|
$200.00
|
-5.86% |
155,884
83.72%
|
186,200
|
Most Recent Note for CLB - 1/16/2014 12:21:16 PM
Consolidating near its 50 DMA line. Prior lows in the $180 area define near-term support to watch. The 10/23/13 mid-day report cautioned members - "Reported earnings +20% on +11% sales revenues for the Sep '13 quarter. Found support near its 50 DMA line and in early September it broke out of a new base formed since noted with caution in the 7/18/13 mid-day report - 'Quarterly sales revenues rose +14% and earnings rose +7% for the Jun '13 quarter, below the investment system's +25% minimum guideline concerning the C criteria for a 4th consecutive quarter. Annual earnings growth has been strong following a dip in its FY '09 earnings.'"
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CPHD
- NASDAQ - ELECTRONICS - Scientific & Technical Instrum
Cepheid
|
$49.73 |
+1.01
2.07%
|
$49.85
|
$48.85
|
1.80% |
603,087
124.27%
|
485,300
|
Most Recent Note for CPHD - 1/16/2014 12:24:35 PM
Hitting a new 52-week high with today's 3rd consecutive gain backed by above average volume. Quarterly and annual earnings (C and A criteria) history has not been a match with the fact-based investment system's guidelines.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CRZO
- NASDAQ - ENERGY - Independent Oil & Gas
Carrizo Oil & Gas Inc
|
$43.73 |
-0.65
-1.46%
|
$46.49
|
$47.87
|
-8.65% |
1,155,198
85.56%
|
1,350,200
|
Most Recent Note for CRZO - 1/16/2014 12:28:31 PM
Reversed into the red after early gains today challenging its 52-week high. Reported earnings +60% on +50% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Completed a new Public Offering on 11/06/13 and consolidated above and below its 50 DMA line since last noted with caution in the 11/08/13 mid-day report - "Three of the past 4 quarterly earnings comparisons through Jun '13 showed greater than +25% increases (C criteria). Up and down annual earnings (A criteria) history remains a fundamental flaw."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GMED
- NYSE - CHEMICALS - Specialty Chemicals
Globus Medical Inc Cl A
|
$22.96 |
+0.43
1.91%
|
$23.02
|
$22.77
|
0.83% |
440,896
82.94%
|
531,600
|
Most Recent Note for GMED - 1/16/2014 12:30:28 PM
Hitting new 52-week highs with today's 3rd consecutive gain, rallying this week with no resistance remaining due to overhead supply. Last noted in the 12/17/13 mid-day report with caution - "Quarterly earnings increases in the 3 latest comparisons through Sep '13 showed growth below the +25% minimum guideline (C criteria)."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IGTE
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Information Technology Service
Igate Corp
|
$37.77 |
-2.44
-6.07%
|
$39.42
|
$41.41
|
-8.79% |
1,016,831
344.69%
|
295,000
|
Most Recent Note for IGTE - 1/16/2014 12:38:18 PM
Rebounded from early lows after gapping down and undercutting its 50 DMA line today, abruptly retreating from its 52-week high with a loss on heavy volume. Stubbornly held its ground and made additional progress with a streak of volume-driven gains since last noted with caution in the 12/09/13 mid-day report. Reported earnings +9% on +10% sales revenues for Dec '13 quarter, below the +25% minimum earnings guideline (C criteria) for a 2nd consecutive quarterly comparison. Prior mid-day reports cautioned members - "Sub par sales revenues growth in the +1-6% range, not indicative of great demand for a new (N criteria) product or service. It survived but failed to impress since 12/01/10 when technical damage prompted it to be dropped from the Featured Stocks list."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ILMN
- NASDAQ - DRUGS - Biotechnology
Illumina Inc
|
$124.79 |
+3.67
3.03%
|
$127.00
|
$123.14
|
1.34% |
1,046,488
87.63%
|
1,194,200
|
Most Recent Note for ILMN - 1/16/2014 12:40:16 PM
Gapped up today and hit a new 52-week high while adding to a spurt of considerable volume-driven gains. Reported earnings +10% on +25% sales for the Sep '13 quarter, its 2nd consecutive quarterly comparison below the +25% minimum earnings growth guideline (C criteria). Fundamental concerns remain, as when noted in prior mid-day reports with caution - "Quarterly and annual earnings history (C and A criteria) remains a concern. Sales revenues and earnings growth slumped below guidelines after it was dropped from the Featured Stocks list on 6/17/09. It had just been featured in the May 2009 issue of CANSLIM.net News (read here)."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LAZ
- NYSE - Finance-Invest Bnk/Bkrs
Lazard Ltd Cl A
|
$47.37 |
+0.37
0.79%
|
$47.74
|
$48.70
|
-2.73% |
360,730
78.87%
|
457,400
|
Most Recent Note for LAZ - 1/16/2014 12:41:46 PM
Perched at its 52-week high with today's 3rd consecutive volume-driven gain. Held its ground in a tight range after noted in the 12/30/13 mid-day report while tallying a 10th consecutive gain - "Reported improved earnings increases in the Jun and Sep '13 quarters but fundamental concerns remain. Annual earnings (A criteria) history has been up and down."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MGIC
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Application Software
Magic Software Enter Ltd
|
$8.62 |
+0.39
4.74%
|
$8.65
|
$8.35
|
3.23% |
421,734
631.34%
|
66,800
|
Most Recent Note for MGIC - 1/16/2014 12:44:11 PM
Hitting another new 52-week high with today's 2nd big volume-driven gain in a 5 session winning streak while no resistance remains due to overhead supply. Stubbornly held its ground following considerable gains with above average volume. Prior mid-day reports repeatedly cautioned members - "This Israel-based Computer - Tech Services firm's quarterly earnings history has been below the +25% minimum guideline (C criteria) but improved in the Sep '13 quarter. It has a strong annual earnings (A criteria) history. Low priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SMCI
- NASDAQ - COMPUTER HARDWARE - Networking &; Communication Dev
Super Micro Computer Inc
|
$18.06 |
+0.76
4.39%
|
$18.08
|
$17.44
|
3.56% |
255,282
132.82%
|
192,200
|
Most Recent Note for SMCI - 1/16/2014 12:48:04 PM
Hitting new 52-week highs with today's 3rd consecutive gain backed by above average volume. Faces little resistance due to overhead supply up through the $18 level. Found support well above its 50 DMA line since noted in the 12/20/13 mid-day report with caution - "Reported earnings +214% on +14% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Annual earnings history (A criteria) has been up and down."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TARO
- NYSE - DRUGS - Drug Manufacturers - Other
Taro Pharmaceutical Inds
|
$104.49 |
-0.70
-0.67%
|
$105.50
|
$109.18
|
-4.30% |
29,406
103.91%
|
28,300
|
Most Recent Note for TARO - 1/16/2014 12:49:27 PM
Pulling back from its 52-week high toward prior highs with above average volume behind today's 5th consecutive loss following recent volume-driven gains. Prior mid-day reports repeatedly cautioned members - . Reported earnings +47% on +28% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Reported earnings -6% on -4% sales revenues for the Jun '13 quarter, below the +25% minimum guideline (C criteria). The Israel-based Medical - Generic Drugs firm faced no resistance due to overhead supply when noted in prior mid-day reports with caution. The number of top-rated funds owning its shares from 2 in Mar '12 to 23 as of Jun '13, a reassuring sign concerning the I criteria."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TSN
- NYSE - FOOD & BEVERAGE - Meat Products
Tyson Foods Inc Cl A
|
$35.59 |
+0.81
2.33%
|
$35.74
|
$34.92
|
1.92% |
3,982,956
107.39%
|
3,708,900
|
Most Recent Note for TSN - 1/16/2014 12:52:20 PM
Reported earnings +23% on +7% sales revenues for the Sep '13 quarter. Found support above its 200 DMA line during its consolidation then rallied to new highs since last noted with caution in the 8/27/13 mid-day report - "Reported earnings above the +25% minimum guideline (C criteria) in the past 2 quarters through Jun '13, but sales revenues were only in the +2-6% range, not suggesting great demand for new (N criteria) products. Annual earnings history (A criteria) is below the fact-based investment system's guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WNS
- NYSE - DIVERSIFIED SERVICES - Business/Management Services
W N S Holdings Ltd Ads
|
$22.19 |
+0.85
3.98%
|
$22.19
|
$22.61
|
-1.86% |
151,852
104.58%
|
145,200
|
Most Recent Note for WNS - 1/16/2014 12:55:01 PM
Perched within close striking distance of its 52-week high. Reported earnings +41% on +6% sales revenues for the Dec '13 quarter, its 3rd consecutive quarter above the +25% minimum earnings guideline. Sub par sales revenues growth and annual earnings (A criteria) history is not a match with the fact-based investment system. It survived but failed to impress since dropped from the Featured Stocks list on 10/27/09.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|
|
